Please login to the form below
medtech
This page shows the latest medtech news and features for those working in and with pharma, biotech and healthcare.
Adaptive innovation
I had the pleasure of this experience recently when playing ‘sounding board’ to the chief marketing officer (CMO) of a mid-sized company that straddles pharma and medtech.
Latest news
-
C-Suite keystones
Two kinds of CEOs. While researching my book Leadership in the Life Sciences, I interviewed a whole series of CEOs from pharma, medtech and other life sciences companies.
-
Johnson & Johnson to acquire Abiomed in deal worth $16.6bn
portfolio. The transaction will boost J&J’s MedTech as a cardiovascular innovator, advancing the standard of care in one of healthcare’s largest unmet needs, heart failure and recovery, the ... He continued: “We have committed to enhancing our
-
Brainomix set to collaborate with NCIMI to assess AI-powered tech in lung cancer care
Brainomix, the artificial intelligence (AI) medtech solutions company is set to collaborate with the National Consortium of Intelligent Medical Imaging (NCIMI, hosted at the University of Oxford) alongside three selected NHS
-
GCI Health announces expansion into the Middle East
pharmaceutical and MedTech companies.
-
In sickness and in health
Paradigm shifts. When I’m asked by pharma or medtech companies to help them predict and prepare for the future, the biggest issue I face is that we’re often looking
More from news
Approximately 1 fully matching, plus 46 partially matching documents found.
Latest Intelligence
-
Working together to achieve better patient pathways
Wilmington combines core expertise across pharma, MedTech and the NHS with cloud-based technology, data visualisation tools and access to senior leaders and policymakers, and specialises in developing strategies that support
-
Cross-functional alignment
When I used this ‘bounded rationality’ model as way of looking at cross-functional behaviour in pharma and medtech companies, what I found was a cause and effect pattern, as summarised ... the practical application of my research in pharma and
-
The future of medtech is in the past
Siren voices within the sector fear that this regulatory burden alone may threaten the resilience of manufacturers and their products, particularly SMEs that make up 95% of the medtech market. ... Our domestic medtech industry was conspicuous by its
-
FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics
strong. During the pandemic, this was no different: pharma, biopharma, biotech and medtech companies from the two regions joined forces and with logistics partners, were focused on developing and delivering products
-
All change – how untangling human behaviour can encourage better health
The levers for change are lined up. Triducive believes that measuring the impact of opinion on creating behaviour change is crucial to develop effective strategies across healthcare, pharma and MedTech markets.
More from intelligence
Approximately 2 fully matching, plus 26 partially matching documents found.
Latest appointments
-
Research Partnership announces two new senior leadership hires
Sue Wild will be joining as president, US pharma and Tom Donnelly as a director in the US MedTech division. ... Research Partnership has announced the appointments of Sue Wild as president, US pharma and Tom Donnelly as a director in the US MedTech
-
Research Partnership appoints Hannah Osborn to MedTech director role
Osborne has previously worked at Ipsos and IQVIA. Research Partnership has appointed Hannah Osborn as a MedTech director in its London, UK office. ... Previously, she worked for Ipsos as director for its MedTech Asia-Pacific (APAC) team, and for IQVIA as
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Aaron Platt joined as Senior Research Executive and Dominika Klubek joined as Research Manager, both within the MedTech team.
-
Healthcare comms appointments
In her new post, Plant will lead the group’s MedTech services, which include healthcare data, education, information and analytics. ... nearly 20 years, Sue will be a great asset to the MedTech team.”.
-
Weekly comms appointments
With ten years’ experience working in PR and digital communications, Knott has worked with a variety of clients from traditional pharma and medtech to consumer brands.
More from appointments
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium
Mtech Access invite Pharma and MedTech market access teams to join guest speakers Penny Dash and Paul Miller at their NHS Transformation Symposium on Tuesday 26th September. ... Mtech Access invite market access teams from Pharmaceutical and MedTech
-
Mtech Access
Our areas of expertise include:. Our clients include top-20 Pharmaceutical and Medical Device companies, as well as smaller specialist biopharma and medtech companies. ... Mtech Access invite Pharma and MedTech market access teams to join guest speakers
-
Research Partnership makes two senior appointments to bolster its US and MedTech operations
Research Partnership is delighted to announce the appointments of Sue Wild as President, US Pharma in the US and Tom Donnelly as a Director in the US MedTech division. ... Sabera Hyderally, who was leading the Fort Washington office, will focus
-
CHASE MedTech Outsourcing Solutions
Are you looking for a fast, flexible and affordable solution to your MedTech sales team?
-
Case study: How segmentation of treaters guided a novel product launch in the allergy space
Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment of Serious Allergic Reactions. Our client developed a novel product
More from PMHub
Approximately 23 fully matching, plus 41 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
